Drug Discovery World

AUGUST 5, 2022

We have a number of exciting milestones coming up,” reveals Hayes, “including preparing for our first user trial of chip synthesised DNA. from 2002 as a Protein Engineer and major contributor to its disruptive NGS technology. Looking ahead. Before joining Evonetix, Sanches-Kuiper was at Solexa (then Illumina Inc.)

DNA 130

DNA Engineering Cell Biology Doctors 130

Drug Target Review

FEBRUARY 29, 2024

In many STEM graduate programs today, even more women are matriculating, earning doctoral degrees, and advancing into academia. Dr Van Laar has also been an investigator in clinical trials for neurodegenerative diseases, including multiple gene therapy studies for Parkinson’s disease.

Therapies 111

Therapies Disease Clinical Trials Science 111

The Pharma Data

JUNE 18, 2021

2 In fact, research has shown that patients reported a high (88%) satisfaction rate when they were treated in all three areas, as part of the forehead line clinical trials. Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. . . .

Doctors 52

Doctors FDA Approval Production Treatment 52

Drug Target Review

JUNE 29, 2023

Regarding the NY-ESO programme that we worked on, I started work on that in 2002 before we even knew that we were going to do cell therapy. I think the cell-therapy field has evolved a lot – and is continuing to do so – in the time I’ve been working with this.

Therapies 115

Therapies Science Production Cell Biology 115

PLOS: DNA Science

JUNE 1, 2023

DEB has been a candidate for a gene therapy since 2002. Two clinical trials were conducted and results published in December. RDEB is inherited from two carrier parents. A dominant form – DDEB – is less severe, blistering the hands, feet, knees, and elbows. This DNA Science post from 2018 traces the history of the efforts.

FDA Approval 52

FDA Approval Therapies FDA Disease 52

Drug & Device Law

DECEMBER 4, 2023

2002). “[I]t is not the role of a federal court to expand state law in ways not foreshadowed by state precedent.” Taking the good doctor first, In re Philips Recalled CPAP, Bi-Level Pap, & Mechanical Ventilator Products Litigation , 2023 WL 7019667 (Sp. 2023 WL 7019287, at *52 (citing another trial court case).

Production 52

Production Trials Treatment Pharmaceuticals 52

Drug & Device Law

JUNE 6, 2022

One prescriber “testified that based on her review of all the post-approval data, at the time of trial, she believed the [risk] was still rare.” Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” caused anything. Schering Corp. , 2d 1140, 1148 (N.J.

Testimonials 59

Testimonials Production Pharmaceuticals Treatment 59